About INCEPTOR BIO, LLC
Inceptor Bio is a clinical-stage biotechnology company pioneering next-generation cell therapies to cure cancer, focusing on overcoming challenges in solid tumors through its OUTLAST™ platform.
Development of next-generation cell therapies for cancerMetabolic reprogramming of T cells to thrive in the tumor microenvironment (TME)Enhancing T cell persistence, metabolic fitness, and resistance to exhaustionResearch and development of CAR-T therapies for solid tumors
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INCEPTOR BIO, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.